Search
- May 2
Infinitopes, a cancer vaccine company, describes their technology and what it means to be housed in Oxford's BioEscalator
Lian Ni Lee and Susannah de Jager discuss how quickly Infinitopes has been able to get ready for the clinic.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A